Size-dependent cell uptake of protein-coated graphene oxide nanosheets Q Mu, G Su, L Li, BO Gilbertson, LH Yu, Q Zhang, YP Sun, B Yan ACS applied materials & interfaces 4 (4), 2259-2266, 2012 | 386 | 2012 |
Immunomodulation of nanoparticles in nanomedicine applications Q Jiao, L Li, Q Mu, Q Zhang BioMed research international 2014 (1), 426028, 2014 | 145 | 2014 |
Analytical strategies for detecting nanoparticle–protein interactions L Li, Q Mu, B Zhang, B Yan Analyst 135 (7), 1519-1530, 2010 | 123 | 2010 |
Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFκB activation and reduces its immunotoxicity N Gao, Q Zhang, Q Mu, Y Bai, L Li, H Zhou, ER Butch, TB Powell, ... ACS nano 5 (6), 4581-4591, 2011 | 98 | 2011 |
Interleukin-6 prevents the initiation but enhances the progression of lung cancer Z Qu, F Sun, J Zhou, L Li, SD Shapiro, G Xiao Cancer research 75 (16), 3209-3215, 2015 | 94 | 2015 |
Effective surface charge density determines the electrostatic attraction between nanoparticles and cells G Su, H Zhou, Q Mu, Y Zhang, L Li, P Jiao, G Jiang, B Yan The Journal of Physical Chemistry C 116 (8), 4993-4998, 2012 | 92 | 2012 |
Myeloid STAT3 promotes lung tumorigenesis by transforming tumor immunosurveillance into tumor-promoting inflammation J Zhou, Z Qu, F Sun, L Han, L Li, S Yan, LP Stabile, LF Chen, JM Siegfried, ... Cancer immunology research, 2017 | 74 | 2017 |
A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells F Wang, S Zhai, X Liu, L Li, S Wu, QP Dou, B Yan Cancer letters 300 (1), 87-95, 2011 | 58 | 2011 |
Reducing both Pgp overexpression and drug efflux with anti-cancer gold-paclitaxel nanoconjugates F Li, X Zhou, H Zhou, J Jia, L Li, S Zhai, B Yan PLoS One 11 (7), e0160042, 2016 | 43 | 2016 |
Computer-aided design of carbon nanotubes with the desired bioactivity and safety profiles D Fourches, D Pu, L Li, H Zhou, Q Mu, G Su, B Yan, A Tropsha Nanotoxicology 10 (3), 374-383, 2016 | 42 | 2016 |
NF-κB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8+ T cells for tumor promotion L Li, L Han, F Sun, J Zhou, KC Ohaegbulam, X Tang, X Zang, ... Oncoimmunology 7 (6), e1435250, 2018 | 39 | 2018 |
Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance F Sun, L Li, P Yan, J Zhou, SD Shapiro, G Xiao, Z Qu Nature communications 10 (1), 5324, 2019 | 37 | 2019 |
Anti-tumor selectivity of a novel tubulin and HSP90 dual-targeting inhibitor in non-small cell lung cancer models Q Zhang, S Zhai, L Li, X Li, H Zhou, A Liu, G Su, Q Mu, Y Du, B Yan Biochemical pharmacology 86 (3), 351-360, 2013 | 36 | 2013 |
Leading neuroblastoma cells to die by multiple premeditated attacks from a multifunctionalized nanoconstruct P Jiao, H Zhou, M Otto, Q Mu, L Li, G Su, Y Zhang, ER Butch, SE Snyder, ... Journal of the American Chemical Society 133 (35), 13918-13921, 2011 | 36 | 2011 |
Protective Effects of Calcineurin on Pancreatitis in Mice Depend on Cellular Source L Wen, TA Javed, AK Dobbs, R Brown, M Niu, L Li, A Khalid, M Barakat, ... Gastroenterology, 2020 | 29 | 2020 |
PDLIM2 repression by ROS in alveolar macrophages promotes lung tumorigenesis L Li, F Sun, L Han, X Liu, Y Xiao, AD Gregory, SD Shapiro, G Xiao, Z Qu JCI insight 6 (5), 2021 | 24 | 2021 |
Proteome interrogation using nanoprobes to identify targets of a cancer-killing molecule L Li, Q Zhang, A Liu, X Li, H Zhou, Y Liu, B Yan Journal of the American Chemical Society 133 (18), 6886-6889, 2011 | 19 | 2011 |
Comparison of cancer cell survival triggered by microtubule damage after turning Dyrk1B kinase on and off L Li, Y Liu, Q Zhang, H Zhou, Y Zhang, B Yan ACS Chemical Biology 9 (3), 731-742, 2014 | 17 | 2014 |
Alveolar macrophages inherently express programmed death-1 ligand 1 for optimal protective immunity and tolerance F Sun, L Li, Y Xiao, AD Gregory, SD Shapiro, G Xiao, Z Qu The Journal of Immunology 207 (1), 110-114, 2021 | 14 | 2021 |
The Novel Tubulin Polymerization Inhibitor MHPT Exhibits Selective Anti-Tumor Activity against Rhabdomyosarcoma In Vitro and In Vivo Y Mu, Y Liu, L Li, C Tian, H Zhou, Q Zhang, B Yan PLoS One 10 (3), e0121806, 2015 | 14 | 2015 |